摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氰基3-(2,6-二氯苯基)丙烯酸 | 103447-22-9

中文名称
2-氰基3-(2,6-二氯苯基)丙烯酸
中文别名
——
英文名称
2-cyano 3-(2,6-dichlorophenyl)propenoic acid
英文别名
2-Cyano-3-(2,6-dichlorophenyl)acrylic acid;2-cyano-3-(2,6-dichlorophenyl)prop-2-enoic acid
2-氰基3-(2,6-二氯苯基)丙烯酸化学式
CAS
103447-22-9
化学式
C10H5Cl2NO2
mdl
MFCD09802338
分子量
242.061
InChiKey
YKZIPMODONNFTI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61.1
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-氰基3-(2,6-二氯苯基)丙烯酸 在 sodium tetrahydroborate 、 碳酸氢钠 、 sodium amide 、 potassium hydroxide 作用下, 以 四氢呋喃甲醇乙醇2,4-滴二甲胺盐 为溶剂, 反应 8.0h, 生成 2-chlorobicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid
    参考文献:
    名称:
    Synthesis of hexahydro[2]benzopyrano[4,3-c]pyridines as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions
    摘要:
    Hexahydro[2]benzopyrano[4,3-c]pyridines were synthesized by an intramolecular hetero Diels-Alder reaction. The reaction was applicable to a range of substrates and the products could be easily converted into serotonin 5-HT2C receptor agonists. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.03.054
  • 作为产物:
    描述:
    2,6-二氯苯甲醛氰乙酸吡啶 、 ammonium acetate 作用下, 以 甲苯 为溶剂, 反应 3.0h, 以98%的产率得到2-氰基3-(2,6-二氯苯基)丙烯酸
    参考文献:
    名称:
    Synthesis of hexahydro[2]benzopyrano[4,3-c]pyridines as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions
    摘要:
    Hexahydro[2]benzopyrano[4,3-c]pyridines were synthesized by an intramolecular hetero Diels-Alder reaction. The reaction was applicable to a range of substrates and the products could be easily converted into serotonin 5-HT2C receptor agonists. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.03.054
点击查看最新优质反应信息

文献信息

  • Bicyclo (4.2.0) 1,3,5-octatriene compounds and use as .alpha.-adrenergics
    申请人:ADIR, s.a.r.l.
    公开号:US04567181A1
    公开(公告)日:1986-01-28
    Compounds of the formula: ##STR1## in which: R.sub.1 and R.sub.2 each represent, independently of one another, hydrogen, halogen, alkyl or alkoxy having from 1 to 4 carbon atoms, sulphonamide possibly substituted by an alkyl radical having from 1 to 4 carbon atoms; or together methylenedioxy, n is 0 or 1, in racemic form or in the form of optical isomers, and also their salts of addition with pharmaceutically acceptable acids. Useful in the treatment of ailments and/or conditions which are adrenoreceptor-related, such relationship being well known in the art.
    公式为:##STR1## 其中:R.sub.1和R.sub.2各自独立地代表氢、卤素、烷基或具有1至4个碳原子的烷氧基,磺酰胺可能被1至4个碳原子的烷基基团取代;或者一起成为亚甲二氧基,n为0或1,为外消旋或光学异构体形式,以及它们与药学上可接受的酸的加成盐。在治疗与肾上腺素受体相关的疾病和/或病症方面有用,这种关系在艺术中是众所周知的。
  • TRICYCLIC HETEROCYCLIC DERIVATIVES
    申请人:Davies Keneth
    公开号:US20120232122A1
    公开(公告)日:2012-09-13
    The present invention relates to a tricyclic heterocyclic derivative according to Formula (I), wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to pharmaceutical compositions comprising said tricyclic heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of serotonin mediated disorders, such as obesity.
    本发明涉及一种三环杂环衍生物,其符合公式(I)中定义的变量,或其药学上可接受的盐或溶剂。本发明还涉及包含所述三环杂环衍生物的制药组合物,以及它们在治疗中的用途,例如在治疗或预防血清素介导的疾病,如肥胖症方面的应用。
  • Tricyclic heterocyclic derivatives
    申请人:Davies Keneth
    公开号:US08729274B2
    公开(公告)日:2014-05-20
    The present invention relates to a tricyclic heterocyclic derivative according to Formula (I), wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to pharmaceutical compositions comprising said tricyclic heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of serotonin mediated disorders, such as obesity.
    本发明涉及一种三环杂环衍生物,其符合公式(I)中定义的变量,或其药学上可接受的盐或溶剂。本发明还涉及包含所述三环杂环衍生物的制药组合物,并且它们在治疗中的应用,例如用于治疗或预防由血清素介导的疾病,如肥胖症。
  • Synthesis of hexahydro[2]benzopyrano[3,4-c]pyrroles as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions
    作者:Takao Kiyoi、Mark Reid、Stuart Francis、Keneth Davies、Steven Laats、Duncan McArthur、Anna-Marie Easson、Yasuko Kiyoi、Gary Tarver、Wilson Caulfield、Kirsty Gibson、Grant Wishart、Angus J. Morrison、Julia M. Adam、Peter Ray
    DOI:10.1016/j.tetlet.2011.03.055
    日期:2011.7
    [2]Benzopyrano[3,4-c]pyrroles were synthesized via an intramolecular hetero Diels-Alder reaction. The reaction was applicable to a wide range of substrates and the products could be easily converted into serotonin 5-HT2c receptor agonists. (C) 2011 Elsevier Ltd. All rights reserved.
  • Synthesis of hexahydro[2]benzopyrano[4,3-c]pyridines as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions
    作者:Yasuko Kiyoi、Steven Laats、Takao Kiyoi、Grant Wishart、Angus Brown、Peter Ray
    DOI:10.1016/j.tetlet.2011.03.054
    日期:2011.7
    Hexahydro[2]benzopyrano[4,3-c]pyridines were synthesized by an intramolecular hetero Diels-Alder reaction. The reaction was applicable to a range of substrates and the products could be easily converted into serotonin 5-HT2C receptor agonists. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多